Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate
Morgan E. Grams(New York University), Josef Coresh(Johns Hopkins University), Mark Woodward(UNSW Sydney), Danielle M. Nash(Institute for Clinical Evaluative Sciences), Angharad Marks(NHS Grampian), Angela Yee‐Moon Wang(Texas State University), Juan Jesús Carrero(Danderyds sjukhus), Bénédicte Stengel(Inserm), Sadayoshi Ito(Tohoku University), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Anna Köttgen(University of Freiburg), Frank L.J. Visseren(University Medical Center Utrecht), Mark J. Sarnak(Tufts Medical Center), Shoshana H. Ballew(New York University), Brenda R. Hemmelgarn(University of Alberta), Sankar D. Navaneethan(Baylor College of Medicine), Kevin Ho(Geisinger Medical Center), David Naimark(Sunnybrook Health Science Centre), Yingying Sang(Kidney Research UK), Hiddo J.L. Heerspink(University Medical Center Groningen), Ognjenka Djurdjev, Andrew S. Levey(Tufts Medical Center)
Cited by 202
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2021|6.1k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k